EUVIMEDEUVIMED entdecken
Crossref

Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug‐resistant epilepsy

Michelle Guignet iD, Jonathan Vuong, Nicholas Uribe, Ticha Ballapapinan, H Steve White

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Michelle Guignet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Epilepsy Drug Discovery, Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Resistant Epilepsy, Carbamazepine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: UW School of Pharmacy, NCATS NIH HHS, Department of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Drug‐resistant epilepsy affects 30% of patients who have uncontrolled seizures despite current antiseizure medications (ASMs). Preclinical drug screening often uses acute dosing and evoked seizures, which may not fully capture the complexities of drug resistance and human treatment regimens. We introduce a novel experimental paradigm that incorporates clinical treatment regimens, pharmacokinetic monitoring and behavioural tolerability assessments to accurately model drug‐resistant epilepsy in animal models. Experimental Approach Rats with epilepsy following kainic acid‐induced status epilepticus were enrolled in a triple cross‐over study to evaluate the dose‐dependent efficacy and tolerability of three commonly used ASMs: ‐ lamotrigine, levetiracetam and carbamazepine. Each medication was delivered in rodent chow for 2 weeks via our automated system, maintaining steady‐state exposures measured by pharmacokinetic sampling. Seizure control was monitored via 24/7 videoEEG and behavioural tolerability was evaluated using minimal motor impairment and hyperexcitability assays. Key Results Chronic oral dosing with carbamazepine and levetiracetam reduced seizure frequency by more than 50% in over half the animals at clinically relevant doses. Lamotrigine, however, was either ineffective or worsened seizures at toxic doses, increasing both convulsive and clustered seizures. Levetiracetam was well tolerated, while carbamazepine impaired motor function at the highest dose. Lamotrigine led to increased hyperactivity and aggressive behaviour at all doses. Conclusion and Implications This study highlights the need for preclinical models that better reflect human epilepsy, considering both efficacy and side effects in drug development. Our findings emphasize the complexity of drug responses and underscore the importance of improved models for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDrug Resistant EpilepsyCarbamazepineAnimalsMaleRatsLevetiracetamLamotrigineRats, Sprague-DawleyKainic AcidDose-Response Relationship, DrugDisease Models, AnimalDrug Evaluation, PreclinicalCross-Over StudiesSeizures

Stichwörter der Autor:innen

clinical translationpersonalized medicinepharmaco‐resistancepreclinical modelstherapeutic monitoring

Substanzen

AnticonvulsantsLevetiracetamLamotrigineCarbamazepineKainic Acid

Autor:innen und Institutionen

  • Center for Epilepsy Drug Discovery, Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA.

ORCID-Profile: Michelle Guignet

Förderung

  • UW School of Pharmacy
  • NCATS NIH HHS
  • Department of Pharmacy
  • American Epilepsy Society
  • National Center for Advancing Translational Sciences

Zitieren

APA

Guignet, M., Vuong, J., Uribe, N., Ballapapinan, T., & White, H. S. (2025). Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug‐resistant epilepsy. British Journal of Pharmacology. https://doi.org/10.1111/bph.70076

Vancouver

Guignet M, Vuong J, Uribe N, Ballapapinan T, White HS. Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug‐resistant epilepsy. British Journal of Pharmacology. 2025. doi:10.1111/bph.70076

BibTeX
@article{Guignet2025,
  author = {Guignet, Michelle and Vuong, Jonathan and Uribe, Nicholas and Ballapapinan, Ticha and White, H Steve},
  title = {Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug‐resistant epilepsy},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70076}
}
Kostenlos starten →